Bvf Inc Portfolio Holdings

Bvf Inc

  • $2.67 Billion
  • Q4 2024

Bvf Inc has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.67 Billion distributed in 53 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $1.05B, Kymera Therapeutics, Inc. with a value of $208M, Revolution Medicines, Inc. with a value of $183M, Axsome Therapeutics, Inc. with a value of $117M, and Mirum Pharmaceuticals, Inc. with a value of $116M.

Examining the 13F form we can see an decrease of $474M in the current position value, from $3.15B to 2.67B.

Bvf Inc is based out at San Francisco, CA

Below you can find more details about Bvf Inc portfolio as well as his latest detailed transactions.

Portfolio value $2.67 Billion
Healthcare: $2.67 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.55B
$1.05 Billion 39.28% of portfolio
19,751,284
Q4 2024 Reduced 9.19%
$2.05B
$208 Million 7.77% of portfolio
5,161,801
Q4 2023 Added 8.92%
$3.71B
$183 Million 6.84% of portfolio
4,181,179
Q4 2024 Added 20.2%
$5.54B
$117 Million 4.4% of portfolio
1,388,064
Q4 2024 Added 32.7%
$1.95B
$116 Million 4.33% of portfolio
2,796,513
Q4 2024 Reduced 9.08%
$281M
$95.5 Million 3.57% of portfolio
3,633,743
Q1 2023 Added 0.62%
$1.89B
$73.3 Million 2.74% of portfolio
1,900,015
Q4 2024 Added 2.69%
$728M
$72.8 Million 2.72% of portfolio
10,400,158
Q4 2023 Added 12.13%
$417M
$70 Million 2.62% of portfolio
5,750,683
Q2 2024 Added 79.89%
$536M
$54.8 Million 2.05% of portfolio
3,944,194
Q4 2024 Reduced 15.38%
$222M
$52.7 Million 1.97% of portfolio
19,522,436
Q3 2024 Added 3.65%
$943M
$52.6 Million 1.97% of portfolio
2,288,760
Q4 2024 Added 169.27%
$196M
$45.4 Million 1.7% of portfolio
3,466,000
Q2 2024 New
$1.76B
$43.2 Million 1.62% of portfolio
1,569,422
Q2 2024 Reduced 15.79%
$469M
$38.9 Million 1.46% of portfolio
6,904,050
Q4 2024 Added 962.16%
$135M
$35.9 Million 1.34% of portfolio
7,000,000
Q4 2023 New
$205M
$33.3 Million 1.25% of portfolio
5,715,893
Q4 2024 Reduced 37.43%
$509M
$33.2 Million 1.24% of portfolio
4,333,885
Q4 2024 Reduced 36.38%
$60.4M
$25.7 Million 0.96% of portfolio
6,293,282
Q2 2024 Added 45.45%
$224M
$25 Million 0.94% of portfolio
5,302,000
Q2 2024 New
$142M
$24.4 Million 0.91% of portfolio
2,372,933
Q4 2024 Reduced 45.65%
$545M
$22.4 Million 0.84% of portfolio
2,567,469
Q4 2024 Reduced 23.85%
$24.6M
$20 Million 0.75% of portfolio
16,552,417
Q1 2024 Added 93.54%
$310M
$19.2 Million 0.72% of portfolio
2,764,471
Q4 2024 New
$266M
$17.9 Million 0.67% of portfolio
2,325,000
Q4 2024 New
$77.1M
$15.7 Million 0.59% of portfolio
8,748,629
Q3 2022 Added 136.54%
$151M
$14.9 Million 0.56% of portfolio
2,670,642
Q4 2024 Reduced 63.83%
$37.4M
$14.6 Million 0.55% of portfolio
9,237,556
Q4 2024 New
$55.4M
$13.5 Million 0.51% of portfolio
10,333,600
Q4 2023 Added 24.62%
$42.2M
$9.03 Million 0.34% of portfolio
2,989,474
Q2 2023 New
$36.1M
$8.9 Million 0.33% of portfolio
8,902,972
Q1 2024 New
$52.6M
$6.57 Million 0.25% of portfolio
4,006,564
Q4 2024 Reduced 15.99%
$160M
$6.43 Million 0.24% of portfolio
1,353,968
Q4 2024 Added 205.48%
$54.1M
$5.39 Million 0.2% of portfolio
5,228,461
Q2 2024 Reduced 20.73%
$40.1M
$3.58 Million 0.13% of portfolio
3,853,818
Q1 2024 Reduced 43.75%
$81.4M
$3.05 Million 0.11% of portfolio
1,813,633
Q3 2022 New
$14.7M
$2.39 Million 0.09% of portfolio
9,544,262
Q4 2020 Added 31.75%
$14.9M
$1.72 Million 0.06% of portfolio
2,966,836
Q3 2024 Added 28.31%
$115M
$1.47 Million 0.05% of portfolio
686,040
Q1 2022 Added 25.99%
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 55.43%
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 7.21%
Verastem Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 24.64%
Sab Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2024 New
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 20.88%
Septerna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 6.44%
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Forte Biosciences Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 398.22%

Summary

  • Portfolio
  • No. of Stocks 53
  • Current Value $2.67 Billion
  • Prior Value $3.15 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 5 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 13 stocks
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email